Bumper Offer - Urjas oil Just @ Rs. 1 X
Ramistar 10 Tablet (10) is a commercial drug that is prescribed in the form of Tablet. High BP are some of its major therapeutic uses. Ramistar 10 Tablet (10) also has some secondary and off-label uses. These are listed below.
The correct dosage of Ramistar 10 Tablet (10) depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Ramistar 10 Tablet (10) include Confusion. Apart from the aforementioned side effects, Ramistar 10 Tablet (10) can also lead to other problems, which have been listed below. Such side effects of Ramistar 10 Tablet (10) normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Ramistar 10 Tablet (10)'s effect during pregnancy is Severe and Mild while nursing. Warnings related to Ramistar 10 Tablet (10)'s effects on the liver, heart and kidney, if any, have been listed below.
Ramistar 10 Tablet (10) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Ramistar 10 Tablet (10) in conditions like Angioedema, Heart Failure, Low Blood Pressure (Hypotension). The section on Ramistar 10 Tablet (10) contraindications lists all such conditions.
Additionally, Ramistar 10 Tablet (10) may also adversely react with other medicines. Refer to the list below for further details.
You should also be aware that Ramistar 10 Tablet (10) is not safe while driving, and is not addiction.
Ramistar 10 Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Ramistar 10 Tablet (10) is used -
Mild
Common
Is the use of Ramistar 10 Tablet (10) safe for pregnant women?
Ramistar should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Ramistar 10 Tablet (10) safe during breastfeeding?
Ramistar may have very limited harmful effects for breastfeeding women.
What is the effect of Ramistar 10 Tablet (10) on the Kidneys?
Ramistar rarely affects the kidneys.
What is the effect of Ramistar 10 Tablet (10) on the Liver?
Ramistar has very mild side effects on the liver.
What is the effect of Ramistar 10 Tablet (10) on the Heart?
Ramistar may have mild side effects on the heart. Most people will never see any effect on the heart.
Ramistar 10 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ramistar 10 Tablet (10) unless your doctor advises you to do so -
Is this Ramistar 10 Tablet (10) habit forming or addictive?
Ramistar 10 Tablet (10) does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Ramistar 10 Tablet (10) can make you feel drowsy.
Is it safe?
Ramistar 10 Tablet (10) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Ramistar 10 Tablet (10) in mental disorders is not effective.
Interaction between Food and Ramistar 10 Tablet (10)
Taking Ramistar 10 Tablet (10) with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Ramistar 10 Tablet (10)
It is difficult to say anything about the effect of Ramistar 10 Tablet (10) and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503